METHOD FOR THE TREATMENT OF SECONDARY GLAUCOMA IN PATIENTS WITH PSEUDOEXFOLIATIVE SYNDROME AND DISLOCATION OF THE INTRAOCULAR LENS Russian patent published in 2022 - IPC A61F9/07 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to ophthalmology. The dislocated intraocular lens (IOL) is sutured to the iris with two interrupted sutures. An antiglaucoma operation of a penetrating type is performed, in which a conjunctival incision is made, a superficial scleral flap (SSL) is cut out. At the same time, in patients with pseudoexfoliative syndrome, after IOL suturing, basal coloboma of the iris is performed through corneal paracentesis at 11 or 13 hours. After that, a conjunctival incision is made on the free area of the L-shaped sclera, starting the incision perpendicular to the limbus, 1 mm long. Then it is extended along the limbus by 4 mm, the operating area under the conjunctiva is released by temporarily moving the conjunctiva. The episcleral vessels are coagulated, the PSL is cut out with the base to the limbus 5 mm wide and 4 mm high, the sclera thickness is 1.0 mm in the limbus zone and the strip of the ciliary body is exposed distal to the limbus. Then, at the place of transition of the cornea to the sclera, a drainage hole is formed at an angle of 15 degrees to the plane of the iris. 0.2 ml of 1% sodium hyaluronate - Provisk is injected into the anterior chamber. An Ex-PRESS microshunt is implanted using an injector, 0.1 ml of the Healaflow drainage implant is injected under the PSL, two interrupted sutures are applied to the PSL. Next, 0.2 ml of the Healaflow drainage implant is injected under the conjunctiva around the operation area. After that, the operation is completed by sealing the conjunctiva.

EFFECT: method allows preserving visual functions, compensating IOP by creating an additional outflow tract of intraocular fluid with simultaneous reposition of the IOL-capsular bag complex; restore the anatomy of the anterior segment of the eye with deblockade of the anterior chamber angle, eliminate the contact of the IOL with the ciliary body and open the natural pathways for the outflow of intraocular fluid, which contributes to a persistent hypotensive effect in the early and late postoperative period.

1 cl, 2 ex